1. Home
  2. ARVN vs URG Comparison

ARVN vs URG Comparison

Compare ARVN & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$7.85

Market Cap

600.2M

Sector

Health Care

ML Signal

N/A

Logo Ur Energy Inc (Canada)

URG

Ur Energy Inc (Canada)

N/A

Current Price

$1.15

Market Cap

608.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ARVN
URG
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
608.7M
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
ARVN
URG
Price
$7.85
$1.15
Analyst Decision
Buy
Strong Buy
Analyst Count
19
5
Target Price
$15.05
$2.57
AVG Volume (30 Days)
705.4K
5.2M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
1.70
N/A
Revenue
$262,600,000.00
$27,207,000.00
Revenue This Year
N/A
$200.42
Revenue Next Year
N/A
$98.46
P/E Ratio
$4.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.97
$1.12
52 Week High
$14.22
$2.35

Technical Indicators

Market Signals
Indicator
ARVN
URG
Relative Strength Index (RSI) 33.46 32.01
Support Level N/A N/A
Resistance Level $9.69 $1.46
Average True Range (ATR) 0.32 0.05
MACD -0.11 -0.02
Stochastic Oscillator 0.58 0.00

Price Performance

Historical Comparison
ARVN
URG

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.

Share on Social Networks: